TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/20 16:39 | 2/20/20 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | DO | CEO,COO, | P | 5 | 1.08 | 0 | 5 | 39 | 18 | D | ||||||||||||||
6/7/19 16:05 | 6/5/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | DO | CEO,COO, | P | 1 | 1.26 | 0 | 1 | 8 | 13 | D | ||||||||||||||
5/17/19 16:05 | 5/16/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | DO | CEO,COO, | P.m | 4 | 1.46 | 0 | 3 | 26 | 12 | D | ||||||||||||||
5/15/19 16:04 | 5/13/19 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | DO | CEO,COO, | P.m | 10 | 1.80 | 0 | 5 | 133 | 9 | D | ||||||||||||||
5/31/17 17:28 | 5/30/17 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | O | COO,CFO | P | 3 | 0.4364 | 0 | 8 | 18 | 50 | D | ||||||||||||||
5/23/17 17:40 | 5/19/17 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Latkin Jed | OH | O | COO,CFO | P.m | 11 | 0.4506 | 0 | 25 | 147 | 43 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |